A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Conditions: Colorectal Cancer; Gastric Adenocarcinoma; Esophageal Adenocarcinoma; Gastroesophageal Adenocarcinoma

Interventions: Biological: DISP-10

Sponsors: Dispatch Biotherapeutics; Bristol-Myers Squibb

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 23, 2026Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments